We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy

EP38469
Poster Title: Characterization of the salivary protein repertoire of Covid-19 patients during and after disease
Submitted on 09 Mar 2022
Author(s): Ulrike Resch 1 , Goran Mitulović 2
Affiliations: 1 Dept. Vasc . Biol. Thromb . Res., CPP, Medical University of Vienna, Austria ; 2 Bruker Austria, Vienna, Austria
Poster Views: 422
Submitted on 09 Mar 2022
Author(s): Ulrike Resch 1 , Goran Mitulović 2
Affiliations: 1 Dept. Vasc . Biol. Thromb . Res., CPP, Medical University of Vienna, Austria ; 2 Bruker Austria, Vienna, Austria
Poster Views: 422
Abstract: The COVID 19 pandemic impressively demonstrated how progress in technology, world wide data sharing and knowledge exchange within the scientific community impacts global health. The pandemic underscored the need for multiple diagnostic strategies providing information on disease onset, progression, immunity and infection sequelae. Saliva, being a kind of virulence reservoir for the SARS CoV 2 virus, is a remarkable fluid in terms of diagnostic possibilities. Its molecular composition and specifically its proteome contains information about the nutritional, immunological and disease/health status. The possibility of non invasive (self collection facilitates straightforward multiple sampling over time, providing not just a disease “snap shot” but offering the opportunity to monitor disease progression and therapeutic interventions.Summary: This study underscores the importance of considering practical aspects sample preparation, data acquisition and analysis in clinical proteomics based on DIA acquisition strategies. Our preliminary results on saliva “liquid biopsies” might be used for pharmacological targeting of protease activities that impact disease progression and saliva aerosol disease dissemination.References:
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Related Posters
Pharmacokinetics modeling and optimal dose prediction for a bispecific antibody against CD40 and PD1
Alexandra Diakonova, Oleg Demin Jr, Dmitry Shchelokov, Oleg Demin
Application review of pseudoUridine and its derivatives
BOC Sciences
Science lab Report on H2N2 is the new wily virus driving people to hospitals
Anmol Chipa
H2N2 is the new wily virus driving people to hospitals
Anmol Chipa
AN OVERVIEW OF NANOTECHNOLOGY IN PHARMACY
Utpal Bhui